I'm happy to be first in line for the vaccine. The studies conducted by the various companies will be published and are almost guaranteed to be open for anyone to view - if there's an issue with the studies prior to roll out I can guarantee you it will be mentioned by someone with more credibilit...

I believe there might be a difference in terminology here that is resulting in us disagreeing. When I refer to the efficiency of the vaccine I'm referring to the % chance that the single shot will result in immunity. I believe you're referring to the overall course (multiple shots) when you refer...

Assuming the vaccine has 50% efficiency, this isn't terribly good but this is why we have multiple rounds of shots. If each shot has a 50% chance of seroconverting then two shots per person will lead to 75% immunity for the population. Given the relatively low R0 value of COVID19 compared to meas...